PT  - JOURNAL ARTICLE
AU  - Hamilton, Ashleigh C.
AU  - Donnelly, David W.
AU  - Loughrey, Maurice B.
AU  - Turkington, Richard C.
AU  - Fox, Colin
AU  - Fitzpatrick, Deirdre
AU  - O’Neill, Ciaran E.
AU  - Gavin, Anna T.
AU  - Coleman, Helen G.
TI  - Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: a population-based study
AID  - 10.1101/2021.02.23.21252276
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.23.21252276
4099  - http://medrxiv.org/content/early/2021/02/24/2021.02.23.21252276.short
4100  - http://medrxiv.org/content/early/2021/02/24/2021.02.23.21252276.full
AB  - Background The restructuring of healthcare systems to cope with the demands of the COVID-19 pandemic has led to a reduction in clinical services such as cancer screening and diagnostics.Methods Data from the four Northern Ireland pathology labs was used to assess trends in pathological cancer diagnoses from 1st March to 12th September 2020 overall and by cancer site, gender and age. These trends were compared to the same timeframe from 2017-2019.Results Between 1st March and 12th September 2020 there was a 23% reduction in cancer diagnoses compared to the same time period in the preceding three years. Although some recovery occurred in August and September 2020, this revealed inequalities across certain patient groups. Pathological diagnoses of lung, prostate and gynaecological malignancies remained well below pre-pandemic levels. Males and younger/middle-aged adults, particularly the 50-59 year old patient group, also lagged behind other population demographic groups in terms of returning to expected numbers of pathological cancer diagnoses.Conclusions There is a critical need to protect cancer diagnostic services in the ongoing pandemic to facilitate timely investigation of potential cancer cases. Targeted public health campaigns may be needed to reduce emerging inequalities in cancer diagnoses as the COVID-19 pandemic continues.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr Ashleigh Hamilton is funded by a HSC R&D Doctoral Fellowship Award from the HSC R&D Division, Public Health Agency, Northern Ireland (HSC R&D Award Reference EAT/5494/18). Professor Helen Coleman is funded by a Cancer Research UK Career Establishment Award (Reference:C37703/A25820). Richard Turkington is supported by Cancer Research UK (C50880/A29831), Cancer Focus NI and OGCancer NI The Northern Ireland Cancer Registry is funded by the Public Health Agency, Northern Ireland.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the Northern Ireland Cancer Registry databases (including the waiving of requirement for individual patient consent) and data analysis has been granted by the Office for Research Ethics Committees of Northern Ireland (ORECNI reference 15/NI/0203), recently renewed in October 2020 (REC REF 20-NI-0132).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMonthly reports of data regarding cancer diagnoses in Northern Ireland, on which this study was based, are available on the Northern Ireland Cancer Registry website.